AI Medical Compendium Topic:
Protein Binding

Clear Filters Showing 721 to 730 of 827 articles

Evotuning protocols for Transformer-based variant effect prediction on multi-domain proteins.

Briefings in bioinformatics
Accurate variant effect prediction has broad impacts on protein engineering. Recent machine learning approaches toward this end are based on representation learning, by which feature vectors are learned and generated from unlabeled sequences. However...

Machine-learning scoring functions trained on complexes dissimilar to the test set already outperform classical counterparts on a blind benchmark.

Briefings in bioinformatics
The superior performance of machine-learning scoring functions for docking has caused a series of debates on whether it is due to learning knowledge from training data that are similar in some sense to the test data. With a systematically revised met...

Predicting MHC class I binder: existing approaches and a novel recurrent neural network solution.

Briefings in bioinformatics
Major histocompatibility complex (MHC) possesses important research value in the treatment of complex human diseases. A plethora of computational tools has been developed to predict MHC class I binders. Here, we comprehensively reviewed 27 up-to-date...

The accurate prediction and characterization of cancerlectin by a combined machine learning and GO analysis.

Briefings in bioinformatics
Cancerlectins, lectins linked to tumor progression, have become the focus of cancer therapy research for their carbohydrate-binding specificity. However, the specific characterization for cancerlectins involved in tumor progression is still unclear. ...

Forman persistent Ricci curvature (FPRC)-based machine learning models for protein-ligand binding affinity prediction.

Briefings in bioinformatics
Artificial intelligence (AI) techniques have already been gradually applied to the entire drug design process, from target discovery, lead discovery, lead optimization and preclinical development to the final three phases of clinical trials. Currentl...

The Impact of Crystallographic Data for the Development of Machine Learning Models to Predict Protein-Ligand Binding Affinity.

Current medicinal chemistry
BACKGROUND: One of the main challenges in the early stages of drug discovery is the computational assessment of protein-ligand binding affinity. Machine learning techniques can contribute to predicting this type of interaction. We may apply these tec...

Protein-ligand binding affinity prediction model based on graph attention network.

Mathematical biosciences and engineering : MBE
Estimating the binding affinity between proteins and drugs is very important in the application of structure-based drug design. Currently, applying machine learning to build the protein-ligand binding affinity prediction model, which is helpful to im...

Integrating multi-scale neighbouring topologies and cross-modal similarities for drug-protein interaction prediction.

Briefings in bioinformatics
MOTIVATION: Identifying the proteins that interact with drugs can reduce the cost and time of drug development. Existing computerized methods focus on integrating drug-related and protein-related data from multiple sources to predict candidate drug-t...

Persistent spectral hypergraph based machine learning (PSH-ML) for protein-ligand binding affinity prediction.

Briefings in bioinformatics
Molecular descriptors are essential to not only quantitative structure activity/property relationship (QSAR/QSPR) models, but also machine learning based chemical and biological data analysis. In this paper, we propose persistent spectral hypergraph ...

SAResNet: self-attention residual network for predicting DNA-protein binding.

Briefings in bioinformatics
Knowledge of the specificity of DNA-protein binding is crucial for understanding the mechanisms of gene expression, regulation and gene therapy. In recent years, deep-learning-based methods for predicting DNA-protein binding from sequence data have a...